China Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The China Drug Delivery Devices Market Report is Segmented by Device Type (Nasal (Inhalers and Other Device Types), Implantable, Injectable (Conventional Drug Delivery Devices and Self-Injectable Drug Delivery Devices (Prefilled Syringes, Auto-Injectors, and Other Self-Injectable Drug Delivery Devices)), and Other Device Types), Therapeutic Application (Cardiovascular, Oncology, Autoimmune Disorder, Pulmonary Disease, and Other Therapeutic Applications), and Sales Channel (Hospitals, Pharmacy, and Other Sales Channels). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

China Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

China Drug Delivery Devices Industry Overview

The Chinese drug delivery devices market is highly competitive and consists of several key players. In terms of market share, a few of the major players are currently dominating the market, and some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key players include Gerresheimer AG, Pfizer Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd, Merck & Co. Inc., Novartis AG, Sanofi, GSK PLC, and Baxter.

China Drug Delivery Devices Market Leaders

  1. Becton, Dickinson and Company

  2. Gerresheimer AG

  3. Pfizer Inc.

  4. Teva Pharmaceutical Industries Ltd

  5. Teleflex Medical

  6. *Disclaimer: Major Players sorted in no particular order
China Drug Delivery Devices Market Concentration

China Drug Delivery Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?